Dark Forest Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.98M Buy
+28,809
New +$2.57M 0.19% 163
2026
Q1
– Sell
-27,405
Closed -$2.17M – 862
2025
Q4
$2.17M Buy
27,405
+13,511
+97% +$1.07M 0.1% 361
2025
Q3
$1.05M Sell
13,894
-19,013
-58% -$1.3M 0.04% 722
2025
Q2
$2.27M Buy
32,907
+8,525
+35% +$559K 0.09% 396
2025
Q1
$1.65M Buy
+24,382
New +$1.46M 0.08% 454
2024
Q4
– Sell
-7,416
Closed -$466K – 1018
2024
Q3
$466K Buy
7,416
+271
+4% +$15.8K 0.06% 410
2024
Q2
$422K Buy
+7,145
New +$447K 0.08% 316
2023
Q1
– Sell
-1,782
Closed -$166K – 1227
2022
Q4
$166K Buy
1,782
+1,534
+619% +$148K 0.04% 289
2022
Q3
$24K Buy
+248
New +$24.5K ﹤0.01% 605
2022
Q1
– Sell
-6
Closed -$1K – 1370
2021
Q4
$1K Buy
+6
New +$554 ﹤0.01% 1327
2021
Q3
– Sell
-5,451
Closed -$455K – 1317
2021
Q2
$455K Buy
+5,451
New +$446K 0.2% 42

Other funds holding CVS

Dark Forest Capital Management's CVS Position: Q2 2026 in Review

Dark Forest Capital Management opened a new position in CVS Health (CVS) in Q2 2026: 28,809 shares worth $2.98M. The stake represents 0.19% of the portfolio and ranks #163 among its holdings. This is a return to the name: Dark Forest Capital Management previously reported a position in CVS as recently as Q4 2025.

Dark Forest Capital Management first reported a position in CVS in Q2 2021 and has held it in 11 quarters since. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Dark Forest Capital Management held 28,809 shares of CVS Health worth $2.98M as of Q2 2026.
  • CVS Health was a new Dark Forest Capital Management position in Q2 2026.
  • CVS Health made up 0.19% of Dark Forest Capital Management's portfolio in Q2 2026, its #163 holding.
  • Dark Forest Capital Management first reported a position in CVS Health in Q2 2021 and has held it in 11 quarters since.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.